Virtual Medicinal Product (VMP) - Co-amoxiclav 400mg/57mg/5ml oral suspension
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Co-amoxiclav 400mg/57mg/5ml oral suspension | Start Date 01-10-2024 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- J01CR02
- BNF Codes
-
- BNF code 05010103
Code | Start Date | End Date |
---|---|---|
43801211000001105 | 01-10-2024 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Amoxicillin trihydrate | Based on Base Substance | Amoxicillin | 80 mg | 1 ml |
Potassium clavulanate | Based on Base Substance | Clavulanic acid | 11.4 mg | 1 ml |
Name
Amoxicillin trihydrate
Basis of strength description
Based on Base Substance
BOSS
Amoxicillin
Strength and UOM (Nmr)
80.0
Strength and UOM (Dmr)
1.0
Name
Potassium clavulanate
Basis of strength description
Based on Base Substance
BOSS
Clavulanic acid
Strength and UOM (Nmr)
11.4
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMCo-amoxiclav
-
VMP(Current) Co-amoxiclav 400mg/57mg/5ml oral sus...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
35 ml | 413 | Part VIIIA Category C |
70 ml | 579 | Part VIIIA Category C |